Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013-Reference-Cited by-同舟云学术

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013

Published:2014-10-28 Issue:1 Volume:12 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Ascierto Paolo A,Grimaldi Antonio M,Anderson Ana Carrizosa,Bifulco Carlo,Cochran Alistair,Garbe Claus,Eggermont Alexander M,Faries Mark,Ferrone Soldano,Gershenwald Jeffrey E,Gajewski Thomas F,Halaban Ruth,Hodi F Stephen,Kefford Richard,Kirkwood John M,Larkin James,Leachman Sancy,Maio Michele,Marais Richard,Masucci Giuseppe,Melero Ignacio,Palmieri Giuseppe,Puzanov Igor,Ribas Antoni,Saenger Yvonne,Schilling Bastian,Seliger Barbara,Stroncek David,Sullivan Ryan,Testori Alessandro,Wang Ena,Ciliberto Gennaro,Mozzillo Nicola,Marincola Francesco M,Thurin Magdalena

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-014-0277-z.pdf

Reference124 articles.

1. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ: Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010, 363: 711-723.

2. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA: Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011, 364: 2507-2516.

3. Liebmann C: Regulation of MAP kinase activity by peptide receptor signaling pathway: paradigms of multiplicity. Cell Signal. 2001, 13: 777-785.

4. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J: Mutations of the BRAF gene in human cancer. Nature. 2002, 417: 949-954.

5. Long GV, Trefzer U, Davies MA, Kefford RF, Ascierto PA, Chapman PB, Puzanov I, Hauschild A, Robert C, Algazi A, Mortier L, Tawbi H, Wilhelm T, Zimmer L, Switzky J, Swann S, Martin AM, Guckert M, Goodman V, Streit M, Kirkwood JM, Schadendorf D: Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to thebrain (BREAK-MB): a multicentre, open-label, phase 2 trial. Lancet Oncol. 2012, 13: 1087-1095.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of PD-1/PD-L1 signaling pathway in cancer pathogenesis and treatment: a systematic review;Journal of Cancer Metastasis and Treatment;2024-05-28

2. Selective toxicity of Cistanche tubulosa root extract on cancerous skin mitochondria isolated from animal model of melanoma;Cutaneous and Ocular Toxicology;2022-07-03

3. MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors;International Journal of Molecular Sciences;2020-06-26

4. Cutaneous malignant melanoma and targeted therapy based on the biomarkers;Indian Journal of Medical and Paediatric Oncology;2019

5. Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells;Journal of Experimental & Clinical Cancer Research;2017-12